Medication-Assisted Treatment

Alcohol Use Disorder is characterized by an inability to control or stop alcohol consumption, even when it leads to negative social, occupational or health consequences. It is a chronic disease that can vary in severity from mild to severe.

Opioid Use Disorder involves the compulsive use of opioids, significantly impacting physical, mental and emotional well-being as well as daily life. It can involve prescription pain medications like oxycodone and morphine, synthetic opioids like fentanyl, or illegal drugs like heroin.

Buprenorphine with naloxone, commonly known as Suboxone, alleviates opioid withdrawal symptoms and reduces cravings by binding to the same brain receptors as other opioids. This helps eliminate physical withdrawals, allowing patients to concentrate on their recovery.

Sublocade, an extended-release injectable form of buprenorphine, is administered monthly following an initial seven-day treatment with a buprenorphine-based medication. It releases medication gradually throughout the month.

Our Brixadi treatment offers an extended-release injectable form of buprenorphine for opioid use disorder. You can administer Brixadi once per week or once per month through various injection sites on the body.

We offer Vivitrol treatment, an FDA-approved injectable medication for opioid and alcohol addiction. Vivitrol binds to opioid receptors in the brain, blocking the effects of opioids and reducing cravings. This helps individuals focus on their recovery and treatment plans.